Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial
-
Published:2024-11
Issue:11
Volume:33
Page:107985
-
ISSN:1052-3057
-
Container-title:Journal of Stroke and Cerebrovascular Diseases
-
language:en
-
Short-container-title:Journal of Stroke and Cerebrovascular Diseases
Author:
Cimflova PetraORCID, Alhabli Ibrahim, Bala Fouzi, Horn MacKenzie, Benali Faysal, Buck Brian H, Catanese Luciana, Coutts Prof Shelagh B․, Khosravani Houman, Appireddy Ramana, Tkach Aleksander, Dowlatshahi Dar, Carpani Federico, Field Thalia, Hunter Gary, Hill Prof․ Michael D․, Poppe Alexandre Y․, Ademola Ayoola, Shamy Michel, Sajobi Tolulope T․, Swartz Richard H․, Almekhlafi Mohammed A․, Menon Prof Bijoy K․, Singh Nishita
Reference13 articles.
1. Tenecteplase vs alteplase before endovascular therapy in basilar artery occlusion;Alemseged;Neurology,2021 2. Tenecteplase versus alteplase before thrombectomy for ischemic stroke;Campbell;N Engl J Med,2018 3. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in canada (act): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial;Menon;Lancet,2022 4. AcT trial: protocol for a pragmatic registry-linked randomized clinical trial;Sajobi;Stroke Vasc Interv Neurol,2022 5. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the european-australasian acute stroke study (ecass ii);Larrue;Stroke,2001
|
|